Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts. - Smith CM; Watts B; Evans K; Kosasih H; Mayoh C; Erickson SW; Earley EJ; Neuhauser S; Stearns TM; Philip VM; Chuang JH; de Bock CE; et al. (HemaSphere, 2026)